Endothelin receptor - A blockade decreases ventricular arrhythmias after myocardial infarction in rats

Cardiovascular Research

Volumn 67, Issue 4, 2005, Pages 647-654

  Baltogiannis, Giannis G ^a   Tsalikakis, Dimitrios G ^a   Mitsi, Agathokleia C ^a   Hatzistergos, Konstantinos E ^a   Elaiopoulos, Dimitrios ^a   Fotiadis, Dimitrios I ^a   Kyriakides, Zenon S ^b   Kolettis, Theofilos M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

Arrhythmia (mechanisms); Endothelins; Infarction

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPICARDIUM; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; INCIDENCE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; RAT STRAIN; TREATMENT OUTCOME;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIA; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; MYOCARDIAL INFARCTION; PEPTIDES, CYCLIC; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; TACHYCARDIA, VENTRICULAR; TELEMETRY; VENTRICULAR FIBRILLATION;

EID: 22744435615     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.04.020     Document Type: Article

References (39)

1. J.L. Rouleau, M. Talajic, B. Sussex, L. Potvin, W. Warnica, and R. Davies Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) study J Am Coll Cardiol 27 1996 1119 1127
2. R.J. Myerburg, K.M. Kessler, and A. Castellanos Sudden cardiac death: structure, function, and time-dependence of risk Circulation 85 Suppl I 1992 I2 I10
3. J.P. Loennechen, A. Stoylen, V. Beisvag, U. Wisloff, and O. Ellingsen Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart Am J Physiol 280 2001 H2902 H2910
4. T. Miyauchi, M. Yanagisawa, and T. Tomizawa Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction Lancet 2 1989 53 54
5. T. Omland, R.T. Lie, A. Aakvaag, T. Aarsland, and K. Dickstein Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction Circulation 89 1994 1573 1579
6. F.J. Ramires, V.L. Nunes, F. Fernandes, C. Mady, and J.A. Ramires Endothelins and myocardial fibrosis J Card Fail 9 2003 232 237
7. T. Watanabe, N. Suzuki, N. Shimamoto, M. Fujino, and A. Imada Contribution of endogenous endothelin to the extension of myocardial infarct size in rats Circ Res 69 1991 370 377
8. I. Sharif, K.A. Kane, and C.L. Wainwright Endothelin and ischemic arrhythmias-antiarrhythmic or arrhythmogenic? Cardiovasc Res 39 1998 625 632
9. M. Raschack, F. Juchelka, and G. Rozek-Schaefer The endothelin-A antagonist LU135252 suppresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling J Cardiovasc Pharmacol 31 1998 145 148
10. A.M. Alberola Aguilar, F. Revert, A. Moya, J. Beltran, J. Garcia, and E. San Martin Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion Gen Pharmacol 35 2000 143 147
11. H. Vago, P. Soos, E. Zima, L. Geller, V. Kekesi, and T. Andrasi The ET-A receptor antagonist LU135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs Clin Sci (Lond) 103 Suppl 48 2002 223S 227S
12. V. Richard, N. Kaeffer, M. Hogie, C. Tron, T. Blanc, and C. Thuillez Role of endogenous endothelin in myocardial and coronary endothelial injury and ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist Br J Pharmacol 113 1994 869 876
13. T. Szabo, L. Geller, B. Merkely, L. Selmeci, A. Juhasz-Nagy, and F. Solti Investigating the dual nature of endothelin-1: ischaemia or direct arrhythmogenic effect? Life Sci 66 2000 2527 2541
14. A. Garjani, C.L. Wainwright, I.J. Zeitlin, C. Wilson, and S.J. Slee Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats J Cardiovasc Pharmacol 25 1995 634 642
15. M.J. Curtis, and D.J. Hearse Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation J Mol Cell Cardiol 21 1989 21 40
16. C.F. Opitz, G.F. Mitchell, M.A. Pfeffer, and J.M. Pfeffer Arrhythmias and death after coronary artery occlusion in the rat Circulation 92 1995 253 261
17. T. Horacek, M. Neumann, S. Mutius, M. Budden, and W. Meesmann Nonhomogeneous epicardial changes and the bimodal distribution of early ventricular arrhythmias during acute coronary artery occlusion Basic Res Cardiol 79 1984 649 667
18. M.R. Franz Current status of monophasic action potential recording: theories, measurements and interpretations Cardiovasc Res 41 1999 25 40
19. D.G. Tsalikakis, D.I. Fotiadis, T. Kolettis, and L.K. Michalis Automated system for the analysis of heart monophasic action potentials Comput Cardiol 30 2003 339 342
20. R. Mohabir, M.R. Franz, and W.T. Clusin In vivo electrophysiological detection of myocardial ischaemia through monophasic action potential recording Prog Cardiovasc Dis 34 1991 15 28
21. E. Downar, M.J. Janse, and D. Durrer The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart Circulation 56 1977 217 224
22. A.P. Davenport, and B. Battistini Classification of endothelin receptors and antagonists in clinical development Clin Sci (Lond) 103 Suppl 48 2002 1S 3S
23. J.C. Spratt, J. Goddard, N. Patel, F.E. Strachan, A.J. Rankin, and D.J. Webb Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men Br J Pharmacol 134 2001 648 654
24. W.G. Haynes, and D.J. Webb Contribution of endogenous generation of endothelin-1 to basal vascular tone Lancet 344 1994 852 854
25. Z.S. Kyriakides, D.T. Kremastinos, T.M. Kolettis, A. Tasouli, A. Antoniadis, and D.J. Webb Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty Circulation 102 2000 1937 1943
26. K. Harada, J. Kawahara, Y. Okada, H. Uzumaki, M. Kusaka, and T. Tokiwa Effects of KRN4884 (a novel K+ channel opener) levromakalin, nilvadipine and propanolol on endothelin-1-induced heart disorders in anesthetized rats Jpn J Pharmacol 78 1998 261 268
27. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, and R.A. Kloner Myocardial infarct size and ventricular function in rats Circ Res 44 1979 503 512
28. K. Ytrehus, Y. Liu, A. Tsuchida, T. Miura, G.S. Liu, and X. Yang Rat and rabbit heart infarction: effects of anaesthesia, perfusate, risk zone, and method of infarct sizing Am J Physiol 267 1994 H2383 H2390
29. M.J. Walker, M.J. Curtis, D.J. Hearse, R.W.F. Campbell, M.J. Janse, and D.M. Yellon The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion Cardiovasc Res 22 1988 447 455
30. R. Yorikane, H. Koike, and S. Miyake Electrophysiological effects of endothelin-1 on canine myocardial cells J Cardiovasc Pharmacol 17 Suppl 7 1991 S159 S162
31. I. Szokodi, F. Horkay, B. Merkely, F. Solti, L. Geller, and P. Kiss Intraepicardial infusion of endothelin-1 induces ventricular arrhythmias in dogs Cardiovasc Res 38 1998 356 364
32. M. Clozel, C. Qiu, C.-S. Qiu, P. Hess, and J.-P. Clozel Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction J Am Coll Cardiol 39 2002 142 147
33. P. Mulder, V. Richard, G. Derumeaux, M. Hogie, J.P. Henry, and F. Lallemand Role of endogenous endothelin in chronic heart failure. Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics and cardiac remodeling Circulation 96 1997 1976 1982
34. K. Ono, G. Tsujimoto, A. Sakamoto, K. Eto, T. Masaki, and Y. Ozaki Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents Nature 370 1994 301 304
35. F. Duru, M. Barton, T.F. Lüscher, and R. Candinas Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res 49 2001 272 280
36. E.J. Kelso, J.P. Spiers, B.J. McDermott, C.N. Scholfield, and B. Silke Stimulation of L-type Ca2+ current by the endothelin receptor A-selective antagonist, BQ-123 in ventricular cardiomyocytes isolated from the rabbit myocardium Biochem Pharmacol 55 1998 897 902
37. T.R. Crockett, G.A. Scott, N.W. McGowan, K.A. Kane, and C.L. Wainwright Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721 Eur J Pharmacol 432 2001 71 77
38. A.V. Gourine, A.T. Gonon, and J. Pernow Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischaemia-reperfusion Am J Physiol Heart Circ Physiol 280 2001 H1105 H1112
39. T.M. Kolettis, Z.S. Kyriakides, D. Leftheriotis, A. Papalambrou, D.T. Kremastinos, and D.J. Webb Electrophysiologic effects of endothelin receptor-A blockade in patients with coronary artery disease J Interv Card Electrophysiol 8 2003 173 179